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Infiltrative and Cytolytic Activities of Lymphokine-Activated Killer (LAK) 
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a Three-Dimensional Multicellular Spheroid Model 
Kourcm IwASAKI 
Department of Neurosurgery, Kyoto University Medical School 
(Director: Prof. Dr. Haruhiko Kikuchi) 
In the present study, we have investigated not only the infiltrative and cytotoxic activities of lym-
phokine-activated killer (LAK) cells on a tumor mass, but also the ultrastructural cell”to-cell interaction 
between LAK effector cells and target tumor cells during the cytolytic process within a three-dimensional 
solid tumor. A multicellular tumor spheroid (MTS) of a human malignant glioma cel lin巴（U-251MG)
was utilized as a solid tumor model. LAK cells were generated from peripheral blood lymphocytes (PBL) 
of a healthy donor after 4-day culture in the presence of interleukin・2(IL-2). MTSs of 500 μm diameter 
were cocultivated with either LAK cells or non-activated PBL, and then time-sequential kinetic, mor-
phological, and ultrastructural examinations were carried out. 
It was demonstrated that the number of viable tumor cells present within MTSs gradually decreased 
in parallel with the increase in the number ofLAK cells. Morphological analyses revealed that LAK cells 
directly infiltrated toward the inner areas of MTSs and caused a progressive tumor destruction. In con-
trast, PBL hardly exhibited such activities. Ultrastructurally, it was found that the infiltrating LAK effec-
tor cells were composed of heterogeneous subpopulations, T-like cells and large gr釦 ularlymphocyte 
(LGL）ーlikecells, and that both types of lymphocytes tightly adhered to the tumor cells and extended their 
cytoplasmic extensions deeply into the targets which underwent a progressive degeneration. Concering 
the cellular interaction, it was found that these two kinds of LAK cells displayed some distinct ultrastruc-
tural feature in the process of target cell killing. Particularly, it should be stressed that LGL-like LAK 
cells exhibited a significant development of the intracytoplasmic secretory granules, suggesting an associa-
tion with the lethal hit of target cel lysis. 
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multicellular tumor spheroid (MTS）は間質や血管を
持たないものの，その3次元構造より固形屋場モテソレ
として有用と考えられている2,35). このため MTSモ
デルは， monolayerあるL、は singlecel suspension type 
の標的細胞でiiとらえられない化学療法や放射線療法
の固形腫蕩に対する効果を評価するために用いられて




















の作成はまず， subconfluent の状態の単層培養 U‘
251MG 細胞を0.1%トリプンンおよび0.01% EDTA 
で処理し， phosphatebu百eredsaline (PBS）で2回洗浄
した後， 5x 105/mlのsinglecell suspensionとした．続
いて， JOmlの singlecell suspensionを密栓をした50・
ml三角フラスコを用いて， 37°C,100 rpmで振渥猪養




健常人の末梢血を Ficoll-Paque (Pharmacia Fine 
Chemicals, AB Uppsala, Sweden）比重遠沈法にて分離
ta『get. U-251MG {malignant astrocytoma derived cel line) 
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Fig. 1 Experimental design. 











に対する抗 CD3(OKT3) (Ortho Pharmaceutical Co., 
Rarit四， NJ,USA）モノクロ一ナノレ抗体およびNatural
Killer (NK) cel マーカーに対する抗 CD16(Leu lib) 
(Becton Dickinson, Mountain View, CA, USA）モノク
~·；：璽F凡識障色 C
_.&• - ・JI- ・¥ . :.-. 
ローナル抗体を 1次抗体として染色し，フローサイト





Dulbecco’s modified MEM （日水製薬） (D’MEM完全
培地と呼ぶ）を用いた．また， リンパ球と K562, 
Daudi の培養には同様の FCS と抗生物質を含む
RPM! 1640 （白水製薬） (RPMI完全矯地と呼ぶ）を
用いた．培養条件は 37°C,95%剖r/5%CO，とした
4) MTSとリンパ球との混合培地
96穴 microplate(Corning, NY, USA）の各 wellに
MTS 1個と LAK細胞 1×106個を入れ， 2U/mlの
Fig. 2 加forphologyof a control恥1TS.
In a, a toluidine blue-stained cross section shows that a control MTS of approximately 500・μmdiameter 
consists of multiple tumor cels arranging in multilayers. Light microscopy, X 180. In b, MTS h出 a
spherical appearance and a smooth surface. SEM, bar=50 μ. Inc (a higher magnification ofb), the sur 
face of MTS iscovered by numerous tumor cels with multiple cel processes. SEM, bar=5 μ. Ind, spin-
dle-shaped tumor cells are seen in MTS. Each tumor cel is characterized by an elongated and bizarre 














































Table 1 Cytotoxic and phenotypic characteristics of 
LAK cells and PBLs. 
LAK 
PBL 
% cytotoxicity against' % positive forb 
U-251MG Daudi K562 CD3 CD16 
62.0 
9.8 
57.5 90.5 85.0 16.4 
7.2 41.2 ND ND 
• Assessed by a standard 4・hr51Cr release assay at efec-
tor: target cell ratios of 20 : 1. Each value 
represents the mean of tripricate determination. 
b Analyzed with F ACS as described m“Materials and 
Methods 
ND: not done 
LAK: lymphokine-activated killer 
PBL: peripheral blood lymphocyte 
Table 2 Classification of the grades representing the 
destructive changes in MTSs after coculture 
with LAK cells or PBL 
Grade Histological Findings 
Effectors are in contact with MTS sur-
face, with litle destructive changes 
obse円 edwithin the MTS. 
I Effectors have infiltrated and destroyed 
up to the outer third of the MTS. 
II Effector-infiltration and MTS-destruc-
tion are extended up to the middle third 
of the MTS. 
IV Effector-in自ltration and MTS-destruc-
tion are extended up to the inner third of 
the MTS. 


















Fig. 3 Morphological characteristics of LAK population before coculture 
In a, LAK cells are fairly heterogeneous in the size and the surface appearance. They have 
numerous microvilli which considerably vary in density, length, and thickness. SEM, bar=5 μ 
In b, LAK cells are divided into two distinct types, based on the intracytoplasmic appearance. 
The lymphocytes in the center and left upper corner of this figure is similar to LGL (LGL like 




















































Kinetics of lymphocyte infiltration and tumor cell killing 
•lymph邸内
~ tumor cell 
LAK 






8 6 4 2 cel number ｛×1σ） 2 4 6 8 
Fig. 4 Kinetics of effector cel m自ltrationand tumor cel killing in the cocultured MTSs. 500・μmMTSs were 
cocultured with 1×106 LAK cels or PBLs. After various periods of incubation (12-48 hours), the MTSs 
were dissociated into single cels by trypsinization. Numbers of total viable cels including tumor cels and 
lymphocytes present within the MTSs were counted as described in“Materials and Methods” 
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Fig. 5 Morphological changes of the MTS-surface after cocultures with each effector (SEM). (a and b; after 24 hrs 
with LAK cells, c and d; after 48 hrs with LAK cells, e and f; after 48 hrs with PBL) 
In a, MTS shows an irregular surface. In b (a higher magnification of a), numerous round cells (LAK cells) 
with microvilli are in a direct contact with the surface of the MTS. Inc, destructive changes are so extensive 
that MTS is sponge-like in appearace. In d (a h単＞ermagnification of c), a larger number of LAK cells 
adhere to the surface, and lπegularity of the surface is much more severe. Many crater-like holes are seen 
(asterisks). In e, MTS shows a relatively smooth surface. In f(a higher magnificむonof e), round cells (PBL) 
are in a direct contact with the surface. However, the number is much smaller, and the irregularity of the sur 
face is much milder than that caused by LAK cells in the same stage. bar=50 μ(a, c, d) and 10 μ (b, d, f）ー
46 日外宝第59巻第1号（平成2年 1月）
Fig. 6 Appearance in a crater-like hole of the MTS cocultured with LAK cells for 48 hrs (SEM, higher 





本を用いて行った 各 stageにつき最低20個の MTS
の観察をし，各 grade；ニ属する MTSの数の割合（%）
で表した LAK MTS 群では経時的に破撲像が顕著
になり，混合培養後期にはすべての MTSが gradeIII 
もしくは IVに属した これに対し， PBL-MTS群で
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e 
Fig. 7 Photomicrographs of the cocultured MTSs with each effector (toluidine blue-stained cross sections). (a and b; 
after 24 hrs with LAK cells, c and d; after 48 hrs with LAK cells, e and f; after 48 hrs with PBL). In a, the 
outer half of MTS isdestroyed. Thi目 wasdesignated as Grade III according to our grading of destructive 
changes. ×140. In b (a higher magnification of a), among degenerative tissue, numerous lymphocyte-like 
round cells are seen.×400. In c, almost the whole MTS ischanged into a mass of necrotic tissue, which is 
designated as grade IV.×140. Ind (a higher magni品cationof c), destructive changes are much extensive, 
and the number of in白ltratinground cells is larger.×1000. In e, destructive changes are confined to the 















I III IV 
0 43 57 0 
0 32 45 23 
0 12 58 30 
0 0 55 45 
90 10 0 0 
82 18 0 0 
78 22 0 0 
74 26 0 0 
• 500-μm MTSs were cocultured with 1×106 cells of 
each e仔ector. After various periods of incubation 
(12 48 h), the MTSs were processed for a mor-
phological analysis on the toluidine blue-stained 
serial cross-sections. At least twenty MTSs were 
prepared for each incubation stage of each effector. 























Fig. 8 Representative ultrastructural findings of the MTS cocultured with LAK cells (after 48 hrs）・ The
right upper corner is the surface of this MTS (SURF.). Most of the tumor cells are lysed, and 
show a ghost cell-like appearance. In the left lower corner. stil viable tumor cels are seen. At 
least three round cels, which have completely di仔町entm~rphological features from the tumor 
cels, are invading with their cel processes extending into the intercellular space of the tumor cels 




Fig. 9 Ultrastructure of the interaction ofLAK effector cells (E) and a tumor cel (T) within a MTS. In 
a, typical T-like cells engaged in target cel killing are shown. The effector is in contact with a 
target cell via cel processes噂 bar=1 μ. In b (a higher ma伊 ificationof a), the cel processes ( ar
rows) of the effector are penetrated into the cytoplasm of the target cel. bar=0.3 μ. 
49 
融解能を有していることがわかった． 従って，条件が のであり，養子免疫療法において良好な成績を得るに
揃えば LAK細胞は養子免疫療法の有効なエプ占 ク は解決しなければならない幾つかの間題点があると考
ターになり得ることが示唆された訳である 但し，こ えられる．代表的なものは①エフェクターの数の問題
の結果も LAK細胞にとっては好条件下て、行われたも と，② invivoでの抑制因子14）の存在である．我々の
ヲ乙
111¥'i’ Zi~ う＇ii.~ Zi~ I >;（ι＇il.之年1月，
a MTS Fig. 10 Ultrastructure of infiltrating LGL-like cels. In a, a typical LGL-like cell infiltrating into 
;, shown. The most striking feature isthat its intracytoplasmic organellas are developed. 
bar= I μ. In b (a higher magnification of a), the development of Golgi apparatus (in the left叩－
per corner) and intracytoplasmic granules (arrows) is especially prominent. The m・ 
tracytoplasmic granules are enlarged, and display more complex shapes. bar=0.3 μ. Inc, a 
LGL・likecel is in contact with a target cel which has been completely lysed and shows a ghost 
<el-like appearance. bar=0.3 μ. 
LAK細胞の spheroidtこ対する浸潤能と融解能 51 
Fig. 11 lmmunofiuorescence microscopy of the cocultured MTS with LAK cells for 48 hrs (a血 db: 
stained with anti-CD3 and anti-CD16 respectively). More than 80% of the infiltrating lym-































害性 T リンパ球や NK細胞の標的細胞融解のメカー
ズムに関してはある程度の知見が得られているが
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